- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02045303
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
Healing Rate of Chronic and Sub-Acute Lower Extremity Ulcers Treated With Contact Ultrasound Followed by MIST Therapy: The VIP Ultrasound Protocol
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective pilot study is designed to evaluate the clinical effectiveness of a wound care ultrasound treatment protocol for sub-acute or chronic wounds of the lower extremity and of any etiology. The Viana-Pompeo (VIP) ultrasound protocol consists of high intensity, low frequency, contact ultrasound therapy (with Sonoca-180) followed by low intensity, low-frequency, noncontact ultrasound therapy (with MIST Therapy). Previously published healing rates for each of the ultrasonic therapy modalities will be used as a comparison.
The Physical Therapist will perform the initial assessment and treatment, and devise an individualized plan of care that involves contact ultrasound followed by noncontact ultrasound. Subjects may remain in the study for up to 12 weeks, or up to when end of study criteria is met.
Transition from contact mode to noncontact mode will happen when:
- Wound is sufficiently clean with ≤ 20% of necrotic tissue or adherent slough.
OR
- >= 80% of soft slough is easily removed from the wound bed with mechanical or selective debridement before or after treatment
OR
- Wound bed quality has failed to progress after 3 consecutive contact ultrasound treatments
For the purposes of this study, treatments will be performed 3 times a week. Treatment time will be dependent on the wound area, at least 20 sec/cm2, per standard protocol.
Only the wounds present during Physical Therapy (PT) initial assessment will be included in the research. If the patient develops new wounds during the course of the research, the patient will receive appropriate treatment, but such wounds will not be part of the study.
Patients in the wound clinic setting are allowed to perform home dressing changes as ordered by the physician in addition to the dressing changes performed by the therapist or wound clinic nurse on clinic visit days. Patients and/or caregivers will be trained in dressing changes techniques and must understand the procedure prior to performing dressing changes on their own.
In addition to ultrasonic treatment and dressing changes, wound debridement may be performed each visit as needed. Digital photography and wound measurements will also be performed weekly and as needed.
End of PT wound therapy may be before, at, or after the end of the study period. The beginning of the MIST therapy will depend on the individual characteristics and wound needs.
A minimum of 4 MIST treatments must be completed for a patient's data to be included the data analysis in the acute care setting.
A minimum of 2 treatments per week (goal of 3 per week) must be reached for the 12 week period for a patient's data to be included in the data analysis.
Study Endpoints
Primary endpoint:
- Wound area reduction
- Percent granulation tissue
- Length of the study for ambulatory subjects: 12 weeks from Start of Contact Ultrasound therapy
Secondary endpoint:
- Wound closure at any point within the length of study
- Failure to note improvement in wound area, and/or wound volume, and/or wound bed quality after 4 consecutive weeks of treatment.
- 3 consecutive missed visits, or a total of 7 missed visits
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75231
- Texas Health Resources - Presbyterian Hospital of Dallas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient is referred to Physical Therapy for contact ultrasound (which is included in the VIP protocol);
- Lower extremity (including foot) wound(s) of any etiology;
- Wound(s) presenting with slough, necrotic tissue, and/or non-viable tissue requiring debridement;
- Wound is present for 4 weeks or longer at the start of ultrasonic therapy;
- Insurance approval is obtained for Contact and Noncontact ultrasound treatments, in the ambulatory setting;
- Patient is 18 years of age or older;
- Female patient attesting not to be pregnant;
- Not undergoing Vacuum Assisted Closure (VAC) therapy.
Exclusion Criteria:
- Patient is referred to Physical Therapy for noncontact ultrasound only;
- Wound(s) not on lower extremity;
- Clean wound(s) that do not require debridement;
- Wound onset less than 4 weeks prior to the start of ultrasonic therapy;
- Malignancies on the treatment area;
- Patients in the ambulatory setting whose insurance did not approve them for both contact and noncontact ultrasound therapy;
- Patient is under 18 years of age;
- Female patient attesting to be pregnant;
- VAC Therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ambulatory Wound Clinic
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic.
|
Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy.
Other Names:
Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Wound Area
Time Frame: Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Mean and Standard Deviation of the group's total wound area at day one and last treatment day.
Wound area was measured as Length x Width.
This is to assess the change in area, in order to assess wound progress towards closure.
|
Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Wound Volume
Time Frame: Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Mean and Standard Deviation of the group's total wound volume at day one and last treatment day.
Wound volume was measured as Length x Width X Depth (when able to determine depth).
This is to assess the change in volume, in order to assess wound progress towards closure.
|
Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Wounds With Slough/Eschar Reduction on Visit 2 and Wounds With Slough/Eschar Reduction at Last Visit
Time Frame: Day 2 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Mean and Standard Deviation of the group's percent adherent and/or non-adherent slough present in the wound bed at day one and last treatment day.
This is to assess the change in slough/eschar.
This is to determine progression from contact to noncontact ultrasound therapy, as well as to determine progress of wound bed quality.
|
Day 2 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wounds With Granulation Present on Visit 1 and Wounds With Granulation Present at Last Visit
Time Frame: Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Mean and Standard Deviation of the group's total percent of granulation tissue present in the wound bed at day one and last treatment day.
This is to assess the change in granulation, in order to assess progress of wound bed quality.
|
Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lisley Viana, PTMS, Texas Health Resources - Presbyterian Hospital of Dallas
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00004597
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Ulcer of Lower Extremity
-
ColdplasmatechGerman Federal Ministry of Education and ResearchRecruitingChronic Ulcer of Lower ExtremityGermany
-
Loma Linda UniversityNitric BioTherapeutics, IncTerminatedChronic Ulcer of Lower ExtremityUnited States
-
Amnio Technology, LLCActive, not recruitingChronic Ulcer of Lower ExtremityUnited States
-
Inari MedicalActive, not recruitingDVT | Deep Vein Thrombosis Leg | Chronic DVT of Lower Extremity | Acute DVT of Lower ExtremityUnited States
-
David Grant U.S. Air Force Medical CenterTerminatedWagner Grade 2 Lower Extremity UlcersUnited States
-
Research Center MatrixCompletedChronic Venous Insufficiency | Trophic UlcersRussian Federation
-
Mayo ClinicRecruitingNon-healing Wound | Lower Extremity Wound | Non-Healing Ulcer of SkinUnited States
-
Yonsei UniversityUnknownOsteotomy of Lower ExtremityKorea, Republic of
-
SerenaGroup, Inc.Sanara MedTechActive, not recruiting
-
University of UtahCompletedRotational Malalignment of the Lower ExtremityUnited States
Clinical Trials on Contact Ultrasound Therapy
-
Celleration, Inc.TerminatedWound of SkinUnited States
-
Cardiff and Vale University Health BoardCelleration, Inc.CompletedVaricose UlcerUnited Kingdom
-
Petz Aladar County Teaching HospitalUnknown
-
Stockholm UniversityCompletedProcrastinationSweden
-
University of BergenCompletedDepression | Chronic Obstructive Pulmonary Disease | AnxietyNorway
-
Florida State UniversityNational Institute on Drug Abuse (NIDA)CompletedInsomnia | Substance Use Disorders | Posttraumatic Stress DisorderUnited States
-
Cukurova UniversityCompletedSubacromial Impingement SyndromeTurkey
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Hereditary Malignant NeoplasmUnited States
-
Peking UniversityRecruiting
-
McMaster UniversityCompletedKnee OsteoarthritisCanada